NCLT Approves Resolution Plan for RITE BUILTEC PRIVATE LIMITED
Resolution achieved in overall 450 Days, ending a 15-Year wait for over…
Euro NCAP Boosts Capacity with Approval of DEKRA and TRANSPOLIS Test Centres
Euro NCAP is pleased to announce that DEKRA and TRANSPOLIS have been…
Euro NCAP Boosts Capacity with Approval of DEKRA and TRANSPOLIS Test Centres
Euro NCAP is pleased to announce that DEKRA and TRANSPOLIS have been…
Euro NCAP Boosts Capacity with Approval of DEKRA and TRANSPOLIS Test Centres
Euro NCAP is pleased to announce that DEKRA and TRANSPOLIS have been…
Euro NCAP Boosts Capacity with Approval of DEKRA and TRANSPOLIS Test Centres
Euro NCAP is pleased to announce that DEKRA and TRANSPOLIS have been…
IOC Executive Board proposes Tony Estanguet for election as IOC Member at the 144th Session in Greece
07 January 2025 - Through a vote by correspondence, the Executive Board (EB)…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
Canoo Inc. Announces 1-for-20 Reverse Stock Split Effective December 24, 2024
December 20, 2024 06:00 ET | Source: Canoo, Inc. JUSTIN, Texas, Dec.…
FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
MIAMI--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that…
Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
December 18, 2024 19:08 ET | Source: Mesoblast Limited RYONCIL (remestemcel-L) is…